blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3156413

EP3156413 - GANIRELIX PRECURSOR AND METHOD FOR PREPARING GANIRELIX ACETATE BY USING ANIRELIX PRECURSOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.09.2022
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  01.10.2021
FormerGrant of patent is intended
Status updated on  29.06.2021
FormerRequest for examination was made
Status updated on  20.03.2017
FormerThe international publication has been made
Status updated on  11.01.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Hybio Pharmaceutical Co., Ltd
4th Floor Office Building
Hybio Medicine Park
Hi-Tech Industrial Park Central
Nanshan District
Shenzhen, Guangdong 518057 / CN
[2017/16]
Inventor(s)01 / CHEN, Youjin
4th Floor OfficeBuilding
Hybio Medicine Park
Middle Zone
Hi-Tech Industrial Park, Nanshan District
Shenzhen Guangdong 518057 / CN
02 / LIU, Jian
4th Floor OfficeBuilding
Hybio Medicine Park
Middle Zone
Hi-Tech Industrial Park, Nanshan District
Shenzhen Guangdong 518057 / CN
03 / MA, Yaping
4th Floor OfficeBuilding
Hybio Medicine Park
Middle Zone
Hi-Tech Industrial Park, Nanshan District
Shenzhen Guangdong 518057 / CN
04 / YUAN, Jiancheng
4th Floor OfficeBuilding
Hybio Medicine Park
Middle Zone
Hi-Tech Industrial Park, Nanshan District
Shenzhen Guangdong 518057 / CN
 [2017/16]
Representative(s)Haseltine Lake Kempner LLP
One Portwall Square
Portwall Lane
Bristol BS1 6BH / GB
[N/P]
Former [2021/44]Haseltine Lake Kempner LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
Former [2017/16]Brown, David Leslie
Haseltine Lake LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
Application number, filing date15805742.212.06.2015
[2017/16]
WO2015CN81311
Priority number, dateCN20141026564713.06.2014         Original published format: CN201410265647
[2017/16]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015188774
Date:17.12.2015
Language:ZH
[2015/50]
Type: A1 Application with search report 
No.:EP3156413
Date:19.04.2017
Language:EN
[2017/16]
Type: B1 Patent specification 
No.:EP3156413
Date:03.11.2021
Language:EN
[2021/44]
Search report(s)International search report - published on:CN17.12.2015
(Supplementary) European search report - dispatched on:EP12.12.2017
ClassificationIPC:C07K7/23, C07K1/06, C07K7/06, C07K1/04, C07K1/107
[2017/16]
CPC:
C07K7/06 (EP,US); C07K7/23 (US); C07K1/04 (US);
C07K1/06 (US); C07K1/107 (US); Y02P20/55 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/16]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:GANIRELIXVORLÄUFER UND VERFAHREN ZUR HERSTELLUNG EINES GANIRELIXACETATS MITTELS EINES ANIRELIXVORLÄUFERS[2017/16]
English:GANIRELIX PRECURSOR AND METHOD FOR PREPARING GANIRELIX ACETATE BY USING ANIRELIX PRECURSOR[2017/16]
French:PRÉCURSEUR DU GANIRÉLIX ET PROCÉDÉ DE PRÉPARATION DE L'ACÉTATE DE GANIRÉLIX AU MOYEN DUDIT PRÉCURSEUR DU GANIRÉLIX[2017/16]
Entry into regional phase11.01.2017Translation filed 
11.01.2017National basic fee paid 
11.01.2017Search fee paid 
11.01.2017Designation fee(s) paid 
11.01.2017Examination fee paid 
Examination procedure11.01.2017Examination requested  [2017/16]
11.01.2017Date on which the examining division has become responsible
10.07.2018Amendment by applicant (claims and/or description)
30.06.2021Communication of intention to grant the patent
27.09.2021Fee for grant paid
27.09.2021Fee for publishing/printing paid
27.09.2021Receipt of the translation of the claim(s)
Opposition(s)04.08.2022No opposition filed within time limit [2022/41]
Fees paidRenewal fee
16.05.2017Renewal fee patent year 03
27.06.2018Renewal fee patent year 04
29.04.2019Renewal fee patent year 05
07.05.2020Renewal fee patent year 06
25.06.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL03.11.2021
AT03.11.2021
CY03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
MK03.11.2021
MT03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
TR03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
[2024/42]
Former [2024/29]AL03.11.2021
AT03.11.2021
CY03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
MK03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
TR03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
Former [2024/22]AL03.11.2021
AT03.11.2021
CY03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
MK03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
Former [2024/20]AL03.11.2021
AT03.11.2021
CY03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
Former [2023/25]AL03.11.2021
AT03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
IE12.06.2022
LU12.06.2022
BE30.06.2022
CH30.06.2022
LI30.06.2022
Former [2023/21]AL03.11.2021
AT03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
IE12.06.2022
LU12.06.2022
CH30.06.2022
LI30.06.2022
Former [2023/20]AL03.11.2021
AT03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
IE12.06.2022
Former [2023/08]AL03.11.2021
AT03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
MC03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2023/01]AL03.11.2021
AT03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SI03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2022/49]AL03.11.2021
AT03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2022/35]AT03.11.2021
CZ03.11.2021
DK03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SK03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2022/34]AT03.11.2021
EE03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
NL03.11.2021
PL03.11.2021
RO03.11.2021
RS03.11.2021
SE03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2022/33]AT03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
NL03.11.2021
PL03.11.2021
RS03.11.2021
SE03.11.2021
SM03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2022/25]AT03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
NL03.11.2021
PL03.11.2021
RS03.11.2021
SE03.11.2021
BG03.02.2022
NO03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2022/24]AT03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
NL03.11.2021
PL03.11.2021
RS03.11.2021
SE03.11.2021
BG03.02.2022
GR04.02.2022
IS03.03.2022
PT03.03.2022
Former [2022/23]AT03.11.2021
ES03.11.2021
FI03.11.2021
HR03.11.2021
LT03.11.2021
LV03.11.2021
PL03.11.2021
RS03.11.2021
BG03.02.2022
PT03.03.2022
Former [2022/22]AT03.11.2021
FI03.11.2021
LT03.11.2021
RS03.11.2021
BG03.02.2022
Former [2022/21]AT03.11.2021
RS03.11.2021
BG03.02.2022
Former [2022/19]BG03.02.2022
Documents cited:Search[YD]CN102584945  (SHENZHEN HYBIO PHARMACEUTICAL) [YD] 1-16 *see embodiment 17*;; claims 9,10 *;
 [T]CN104844694  (SHENZHEN HYBIO PHARMACEUTICAL) [T] 1-16* the whole document *;
 [XY]  - FRIEDEMANN HORN ET AL, "Intracellular responses to Gonadotropin-releasing hormone in a clonal cell line of the gonadotrope lineage", MOLECULAR ENDOCRINOLOGY, THE ENDOCRINE SOCIETY, US, (19910101), vol. 5, no. 3, doi:10.1210/MEND-5-3-347, ISSN 0888-8809, pages 347 - 355, XP002361664 [X] 1 * see compound with CAS RN 134365-99-4* [Y] 1-16

DOI:   http://dx.doi.org/10.1210/mend-5-3-347
 [A]  - THOMAS BECKERS ET AL, "Structure-Function Studies of Linear and Cyclized Peptide Antagonists of the GnRH Receptor", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, AMSTERDAM, NL, (20011201), vol. 289, no. 3, doi:10.1006/bbrc.2001.5939, ISSN 0006-291X, pages 653 - 663, XP055430702 [A] 1-16 * page 654, column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.1006/bbrc.2001.5939
International search[A]EP0301850  (SYNTEX INC [US]) [A] 1-16 * , the whole document *;
 [A]EP0443532  (SYNTEX INC [US]) [A] 1-16 * , the whole document *;
 [A]US5212288  (NESTOR JR JOHN J [US], et al) [A] 1-16 * , the whole document *;
 [A]US5767082  (NESTOR JR JOHN J [US], et al) [A] 1-16 * , the whole document *;
 [A]CN1348462  (ZANTARIS AG [DE]) [A] 1-16* , the whole document *;
 [Y]CN102584945  (SHENZHEN HYBIO PHARMACEUTICAL) [Y] 2-16 * , claims 1-10, and description, paragraph [0076] *;
 [PX]CN104231055  (SHENZHEN HYBIO PHARMACEUTICAL) [PX] 1-16 * , claims 1-16 *;
 [XY]  - HORN, F. et al., "Intracellular Responses to Gonadotropin-Releasing Hormone in a Clonal Cell Line of the Gonadotrope Lineage", MOLECULAR ENDOCRINOLOGY, (19910331), vol. 5, no. 3, ISSN 0888-8809, pages 347 - 355, XP002361664 [X] 1 * . and table 2, and table 2 * [Y] 2-16

DOI:   http://dx.doi.org/10.1210/mend-5-3-347
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.